ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

PALIPERIDONUM

Active substance (INN) · ATC N05AX13 · 28 products authorised in Romania
◀ Back
1

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

CodeProtocolStatusRoleSublistGP
N028F PALIPERIDONUM In force medicine of the protocol C1-G15 YES
2

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand nameFormStrengthHolderATCRx
BYANNLI 1000 mgSUSP. INJ. CU ELIB. PREL.1000mgJANSSEN-CILAG INTERNATIONAL NV - BELGIAN05AX13PRF
BYANNLI 700 mgSUSP. INJ. CU ELIB. PREL.700mgJANSSEN-CILAG INTERNATIONAL NV - BELGIAN05AX13PRF
MOPETIA 100 mgSUSP. INJ. CU ELIB. PREL. IN SERINGA PREUMPLUTA100mgZENTIVA, K.S. - REPUBLICA CEHAN05AX13PRF
MOPETIA 150 mgSUSP. INJ. CU ELIB. PREL. IN SERINGA PREUMPLUTA150mgZENTIVA, K.S. - REPUBLICA CEHAN05AX13PRF
MOPETIA 50 mgSUSP. INJ. CU ELIB. PREL. IN SERINGA PREUMPLUTA50mgZENTIVA, K.S. - REPUBLICA CEHAN05AX13PRF
MOPETIA 75 mgSUSP. INJ. CU ELIB. PREL. IN SERINGA PREUMPLUTA75mgZENTIVA, K.S. - REPUBLICA CEHAN05AX13PRF
PALIPERIDONA STADA 100 mgSUSP. INJ. CU ELIB. PREL. IN SERINGA PREUMPLUTA100mgSTADA M&D S.R.L. - ROMANIAN05AX13PRF
PALIPERIDONA STADA 150 mgSUSP. INJ. CU ELIB. PREL. IN SERINGA PREUMPLUTA150mgSTADA M&D S.R.L. - ROMANIAN05AX13PRF
PALIPERIDONA STADA 25 mgSUSP. INJ. CU ELIB. PREL. IN SERINGA PREUMPLUTA25mgSTADA M&D S.R.L. - ROMANIAN05AX13PRF
PALIPERIDONA STADA 50 mgSUSP. INJ. CU ELIB. PREL. IN SERINGA PREUMPLUTA50mgSTADA M&D S.R.L. - ROMANIAN05AX13PRF
PALIPERIDONA STADA 75 mgSUSP. INJ. CU ELIB. PREL. IN SERINGA PREUMPLUTA75mgSTADA M&D S.R.L. - ROMANIAN05AX13PRF
PALIPERIDONA TEVA 100 mgSUSP. INJ. CU ELIB. PREL.100mgTEVA PHARMACEUTICALS S.R.L. - ROMANIAN05AX13PRF
PALIPERIDONA TEVA 150 mgSUSP. INJ. CU ELIB. PREL.150mgTEVA PHARMACEUTICALS S.R.L. - ROMANIAN05AX13PRF
PALIPERIDONA TEVA 50 mgSUSP. INJ. CU ELIB. PREL.50mgTEVA PHARMACEUTICALS S.R.L. - ROMANIAN05AX13PRF
PALIPERIDONA TEVA 75 mgSUSP. INJ. CU ELIB. PREL.75mgTEVA PHARMACEUTICALS S.R.L. - ROMANIAN05AX13PRF
PALMEUX 100 mgSUSP. INJ. CU ELIB. PREL. IN SERINGA PREUMPLUTA100mgADVANZ PHARMA LIMITED - IRLANDAN05AX13PRF
PALMEUX 150 mgSUSP. INJ. CU ELIB. PREL. IN SERINGA PREUMPLUTA150mgADVANZ PHARMA LIMITED - IRLANDAN05AX13PRF
PALMEUX 25 mgSUSP. INJ. CU ELIB. PREL. IN SERINGA PREUMPLUTA25mgADVANZ PHARMA LIMITED - IRLANDAN05AX13PRF
PALMEUX 50 mgSUSP. INJ. CU ELIB. PREL. IN SERINGA PREUMPLUTA50mgADVANZ PHARMA LIMITED - IRLANDAN05AX13PRF
PALMEUX 75 mgSUSP. INJ. CU ELIB. PREL. IN SERINGA PREUMPLUTA75mgADVANZ PHARMA LIMITED - IRLANDAN05AX13PRF
PARNIDO 3 mgCOMPR. CU ELIB. PREL.3mgKRKA, D.D., NOVO MESTO - SLOVENIAN05AX13PRF
PARNIDO 6 mgCOMPR. CU ELIB. PREL.6mgKRKA, D.D., NOVO MESTO - SLOVENIAN05AX13PRF
PARNIDO 9 mgCOMPR. CU ELIB. PREL.9mgKRKA, D.D., NOVO MESTO - SLOVENIAN05AX13PRF
TREVICTA 175 mgSUSP. INJ. CU ELIB. PREL.175mgJANSSEN-CILAG INTERNATIONAL NV - BELGIAN05AX13PRF
TREVICTA 263 mgSUSP. INJ. CU ELIB. PREL.263mgJANSSEN-CILAG INTERNATIONAL NV - BELGIAN05AX13PRF
TREVICTA 350 mgSUSP. INJ. CU ELIB. PREL.350mgJANSSEN-CILAG INTERNATIONAL NV - BELGIAN05AX13PRF
TREVICTA 525 mgSUSP. INJ. CU ELIB. PREL.525mgJANSSEN-CILAG INTERNATIONAL NV - BELGIAN05AX13PRF
XEPLIONSUSP. INJ. CU ELIB. PREL.100mgJANSSEN-CILAG INTERNATIONAL NV - BELGIAN05AX13PRF
XEPLIONSUSP. INJ. CU ELIB. PREL.150mgJANSSEN-CILAG INTERNATIONAL NV - BELGIAN05AX13PRF
XEPLIONSUSP. INJ. CU ELIB. PREL.25mgJANSSEN-CILAG INTERNATIONAL NV - BELGIAN05AX13PRF
XEPLIONSUSP. INJ. CU ELIB. PREL.50mgJANSSEN-CILAG INTERNATIONAL NV - BELGIAN05AX13PRF
XEPLIONSUSP. INJ. CU ELIB. PREL.75mgJANSSEN-CILAG INTERNATIONAL NV - BELGIAN05AX13PRF

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.